XARELTO (rivaroxaban) – Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
XARELTO (rivaroxaban) – Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/68616a-eng.php
Health Canada releases test results of certain sartan drugs
Health Canada releases test results of certain sartan drugs
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/68620a-eng.php
Fluoroquinolone Antibiotics: Safety Communication – Increased Risk of Ruptures or Tears in the Aorta Blood Vessel in Certain Patients
Health Canada Releases Action Plan on Medical Devices
Curso gratuito: Manipulação de Alimentos
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5193104
Avaliação clínica aprova 80% dos doadores de sangue
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5192111
Proibido lote do produto Control PKU Plus 2
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5190588
Cannabis and Alcohol Use During the Holidays
Cannabis and Alcohol Use During the Holidays
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/68608a-eng.php
Treinamento da Farmacopeia Americana está disponível
http://portal.anvisa.gov.br/rss/-/asset_publisher/Zk4q6UQCj9Pn/content/id/5182482